SwanBio Therapeutics Revenue and Competitors

Bala Cynwyd,

Location

$52M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SwanBio Therapeutics's estimated annual revenue is currently $3.3M per year.(i)
  • SwanBio Therapeutics's estimated revenue per employee is $77,500
  • SwanBio Therapeutics's total funding is $52M.

Employee Data

  • SwanBio Therapeutics has 43 Employees.(i)
  • SwanBio Therapeutics grew their employee count by -12% last year.

SwanBio Therapeutics's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
VP Tech Ops and QualityReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
VP, Legal and Intellectual PropertyReveal Email/Phone
5
SVP Program DevelopmentReveal Email/Phone
6
VP Vector Engineering and BioassayReveal Email/Phone
7
Head Portfolio DevelopmentReveal Email/Phone
8
General Counsel & Head Intellectual PropertyReveal Email/Phone
9
Director Quality AssuranceReveal Email/Phone
10
Senior Director Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is SwanBio Therapeutics?

With offices in Philadephia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by an unrelenting passion to solve difficult challenges, and a belief that meaningful discovery is borne of curiosity, collaboration, and compassion. Founded by proven industry leaders with a commitment to positively impacting the lives of people with neurological diseases, SwanBio merges clinical, scientific and drug commercialization expertise. To learn about career opportunities contact us at careers@swanbiotx.com.

keywords:N/A

$52M

Total Funding

43

Number of Employees

$3.3M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SwanBio Therapeutics News

2022-04-17 - SwanBio Therapeutics to Present Preclinical Data on Lead ...

SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...

2022-04-06 - Updated Preclinical Data Support Potential of First AAV-Based ...

SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...

2022-03-22 - SwanBio Therapeutics to Present New Preclinical Data ...

SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...

2020-04-24 - SwanBio Therapeutics Raises $52M in Series A

SwanBio Therapeutics, a Bala Cynwyd, Pa.-based gene therapy company developing medicines to deliver clinical efficacy for the treatment of AMN and other neurological diseases, completed a $52m expanded Series A financing. Syncona Ltd. and Partners Innovation Fund made a $20m investment as part ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.9M4624%N/A
#2
$9.8M494%N/A
#3
$13M50-2%N/A
#4
$3.5M5413%N/A
#5
$8.5M5541%N/A